Sagimet Biosciences Inc (SGMT)

Sep 05, 2026

SGMT Stock Surged 40% And Breached 200-DMA For The First Time In Nearly 3 Months – What’s Got Retail Buzzing? - Stocktwits

Sep 05, 2026

Sep 02, 2026

A drug developer's investor chat is set for Sept. 9 in New York - Stock Titan

Sep 02, 2026

Aug 27, 2026

Enterprise value to EBIT forward of Sagimet Biosciences Inc.Series A – NASDAQ:SGMT - TradingView

Aug 27, 2026

Aug 26, 2026

H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $29 - Moomoo

Aug 26, 2026

Aug 25, 2026

Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026 - TradingView

Aug 25, 2026

Aug 25, 2026

Sagimet plans to start acne drug trial enrollment in Q4 - Investing.com India

Aug 25, 2026

Aug 25, 2026

Sagimet plans to start acne drug trial enrollment in Q4 By Investing.com - Investing.com Canada

Aug 25, 2026

Aug 25, 2026

JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $31 - Moomoo

Aug 25, 2026

Aug 20, 2026

Balyasny Asset Management L.P. Acquires Stake in Sagimet Bioscie - GuruFocus

Aug 20, 2026

Aug 18, 2026

Sagimet Biosciences Inc. Series A Common Stock (NASDAQ: SGMT) Stock Price, News & Analysis - Kalkine

Aug 18, 2026

Aug 17, 2026

Sagimet Biosciences Director George Kemble Exercises Options and Sells 350,987 Shares - Kalkine Media

Aug 17, 2026

Aug 17, 2026

Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record

Aug 17, 2026

Aug 17, 2026

Sagimet Biosciences Eyes U.S. Phase III Acne Study After Positive China Data - MarketBeat

Aug 17, 2026

Aug 15, 2026

Sagimet Biosciences (SGMT) Surges 13.7% to $10.55 as Biotech Momentum BuildsMFI Divergence - vinanet.vn

Aug 15, 2026

Aug 15, 2026

SGMT Q1 2026 Earnings: Narrower-than-Expected Loss Spurs 13.7% Stock RallyGrowth Acceleration Report - vinanet.vn

Aug 15, 2026

Aug 15, 2026

Dimensional Fund Advisors LP Acquires 135,178 Shares of Sagimet Biosciences Inc. $SGMT - MarketBeat

Aug 15, 2026

Aug 15, 2026

Sagimet Biosciences (NASDAQ:SGMT) Cut to "Sell" at Wall Street Zen - MarketBeat

Aug 15, 2026

Aug 14, 2026

SGMT (NASDAQ: SGMT) executive plans 350,987-share stock sale under Form 144 - Stock Titan

Aug 14, 2026

Aug 14, 2026

Sagimet Biosciences (NASDAQ:SGMT) Given New $29.00 Price Target at Citizens Jmp - MarketBeat

Aug 14, 2026

Aug 14, 2026

Citizens raises Sagimet stock price target to $29 on acne drug - Investing.com South Africa

Aug 14, 2026

Aug 14, 2026

Sagimet Biosciences (SGMT): Balyasny group discloses 5.93% ownership in Schedule 13G - Stock Titan

Aug 14, 2026

Aug 13, 2026

FDA Approves Sagimet Biosciences' IND for Phase 3 Denifanstat Acne Study - Kalkine Media

Aug 13, 2026

Aug 13, 2026

Sagimet Biosciences Receives US FDA Clearance for Phase 3 Acne Trial - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Sagimet Biosciences Inc. (SGMT) Stock Price, News, Quote & History - ca.finance.yahoo.com

Aug 13, 2026

Aug 13, 2026

Form 8K Sagimet Biosciences Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Aug 13, 2026

Sagimet gets FDA OK for late-stage acne trial (SGMT:NASDAQ) - Seeking Alpha

Aug 13, 2026

Aug 13, 2026

FDA clears Sagimet’s phase 3 trial for acne treatment denifanstat By Investing.com - Investing.com South Africa

Aug 13, 2026

Aug 13, 2026

Q4 EPS Estimate for Sagimet Biosciences Decreased by Analyst - MarketBeat

Aug 13, 2026

Aug 13, 2026

FDA clears Sagimet’s phase 3 trial for acne treatment denifanstat - Investing.com

Aug 13, 2026

Aug 13, 2026

FDA clears Sagimet Biosciences to begin Phase 3 trial of denifanstat for acne - Investing.com India

Aug 13, 2026

Aug 13, 2026

Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026 - TradingView

Aug 13, 2026

Aug 13, 2026

Sagimet Biosciences Announces FDA Clearance of IND for Phase 3 Denifanstat Acne Trial - Quiver Quantitative

Aug 13, 2026

Aug 13, 2026

Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients - Yahoo Finance

Aug 13, 2026

Aug 13, 2026

Sagimet Biosciences director George Kemble sells $201,146 in shares By Investing.com - Investing.com Canada

Aug 13, 2026

Aug 12, 2026

Sagimet Biosciences director George Kemble sells $201,146 in shares - Investing.com

Aug 12, 2026

Aug 12, 2026

Sagimet Biosciences (NASDAQ:SGMT) Director Sells 20,206 Shares of Stock - MarketBeat

Aug 12, 2026

Aug 12, 2026

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail

Aug 12, 2026

Aug 12, 2026

Sagimet Biosciences (NASDAQ:SGMT) Given New $56.00 Price Target at Canaccord Genuity Group - MarketBeat

Aug 12, 2026

Aug 12, 2026

Why is Sagimet Biosciences stock climbing today? By Investing.com - Investing.com Australia

Aug 12, 2026

Aug 12, 2026

Here's Why We're Not At All Concerned With Sagimet Biosciences' (NASDAQ:SGMT) Cash Burn Situation - simplywall.st

Aug 12, 2026

Aug 12, 2026

Why is Sagimet Biosciences stock climbing today? - Investing.com

Aug 12, 2026

Aug 12, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Aug 12, 2026

Aug 11, 2026

Sagimet Biosciences (SGMT) insider plans 20,206-share stock sale after option exercise - Stock Titan

Aug 11, 2026